Počet záznamů: 1  

Recent advances in deciphering oligodendrocyte heterogeneity with single-cell transcriptomics

  1. 1.
    SYSNO ASEP0566908
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevRecent advances in deciphering oligodendrocyte heterogeneity with single-cell transcriptomics
    Tvůrce(i) Valihrach, Lukáš (UEM-P)
    Matúšová, Z. (CZ)
    Žucha, D. (CZ)
    Klassen, R. (CZ)
    Benešová, Š. (CZ)
    Abaffy, P. (CZ)
    Kubista, M. (CZ)
    Anděrová, Miroslava (UEM-P) RID, ORCID
    Číslo článku1025012
    Zdroj.dok.Frontiers in Cellular Neuroscience. - : Frontiers Media
    Roč. 16, oct. (2022)
    Poč.str.8 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovaoligodendrocyte ; heterogeneity ; scRNA-seq ; snRNA-seq ; populations ; marker genes
    Obor OECDNeurosciences (including psychophysiology
    CEPLX22NPO5107 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Způsob publikováníOpen access
    Institucionální podporaUEM-P - RVO:68378041
    UT WOS000875842100001
    EID SCOPUS85140777633
    DOI10.3389/fncel.2022.1025012
    AnotaceOligodendrocytes (OL) have been for decades considered a passive, homogenous population of cells that provide support to neurons, and show a limited response to pathological stimuli. This view has been dramatically changed by the introduction of powerful transcriptomic methods that have uncovered a broad spectrum of OL populations that co-exist within the healthy central nervous system (CNS) and also across a variety of diseases. Specifically, single-cell and single-nucleus RNA-sequencing (scRNA-seq, snRNA-seq) have been used to reveal OL variations in maturation, myelination and immune status. The newly discovered immunomodulatory role suggests that OL may serve as targets for future therapies. In this review, we summarize the current understanding of OL heterogeneity in mammalian CNS as revealed by scRNA-seq and snRNA-seq. We provide a list of key studies that identify consensus marker genes defining the currently known OL populations. This resource can be used to standardize analysis of OL related datasets and improve their interpretation, ultimately leading to a better understanding of OL functions in health and disease.
    PracovištěÚstav experimentální medicíny
    KontaktLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Rok sběru2023
    Elektronická adresahttps://www.frontiersin.org/articles/10.3389/fncel.2022.1025012/full
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.